These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22920489)

  • 1. Appropriate anti-thrombotic/anti-thrombin therapy for thrombotic lesions.
    Iqbal Z; Rana G; Cohen M
    Curr Cardiol Rev; 2012 Aug; 8(3):181-91. PubMed ID: 22920489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic treatment in acute coronary syndromes.
    Hoole SP; Saw J
    Minerva Med; 2010 Aug; 101(4):215-38. PubMed ID: 21030935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost Effectiveness of Antiplatelet and Antithrombotic Therapy in the Setting of Acute Coronary Syndrome: Current Perspective and Literature Review.
    Fanari Z; Weiss S; Weintraub WS
    Am J Cardiovasc Drugs; 2015 Dec; 15(6):415-27. PubMed ID: 26068886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?
    Huber K; Bates ER; Valgimigli M; Wallentin L; Kristensen SD; Anderson JL; Lopez Sendon JL; Tubaro M; Granger CB; Bode C; Ohman EM; Steg PG
    Am Heart J; 2014 Nov; 168(5):611-21. PubMed ID: 25440788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in ST-segment elevation myocardial infarction.
    Wong CK; White HD
    Expert Opin Pharmacother; 2011 Feb; 12(2):213-23. PubMed ID: 21226633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic Approaches in Acute Coronary Syndromes: Optimizing Benefit vs Bleeding Risks.
    Singh M; Bhatt DL; Stone GW; Rihal CS; Gersh BJ; Lennon RJ; Narula J; Fuster V
    Mayo Clin Proc; 2016 Oct; 91(10):1413-1447. PubMed ID: 27712639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy.
    Kwa AT; Rogers JH
    J Interv Cardiol; 2008 Apr; 21(2):107-17. PubMed ID: 18248357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
    Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
    Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.
    Dyke CM
    Am Heart J; 1999 Oct; 138(4 Pt 2):307-16. PubMed ID: 10502236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?
    Silva MA; Donovan JL; Gandhi PJ; Volturo GA
    Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the Role for Glycoprotein IIb/IIIa Inhibitor Use in the Catheterization Laboratory in the Current Era?
    Rubboli A; Patti G
    Curr Vasc Pharmacol; 2018; 16(5):451-458. PubMed ID: 29345590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombotic treatment in acute coronary syndrome].
    Darius H; Rupprecht HJ; Genth-Zotz S; Wittlinger T; Zotz R
    Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S17-22. PubMed ID: 24446037
    [No Abstract]   [Full Text] [Related]  

  • 14. Triple antiplatelet therapy in acute coronary syndromes.
    Valgimigli M; Minarelli M
    Drugs; 2011 Sep; 71(13):1703-19. PubMed ID: 21902293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: Insights from the TRANSLATE ACS study.
    Ibrahim H; Kaltenbach LA; Hess CN; Recchia T; Effron MB; Stone GW; Wang TY
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):E204-E210. PubMed ID: 30244509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet and antithrombin strategies in acute coronary syndrome: state-of-the-art review.
    Showkathali R; Natarajan A
    Curr Cardiol Rev; 2012 Aug; 8(3):239-49. PubMed ID: 22935021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimizing bleeding complications of percutaneous coronary intervention and glycoprotein IIb-IIIa antiplatelet therapy.
    Juran NB
    Am Heart J; 1999 Oct; 138(4 Pt 2):297-306. PubMed ID: 10502235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of IIb/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes: A meta-analysis of pivotal trials.
    Roule V; Agueznai M; Sabatier R; Blanchart K; Lemaître A; Ardouin P; Collet JP; Milliez P; Montalescot G; Beygui F
    Platelets; 2017 Mar; 28(2):174-181. PubMed ID: 27657930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry.
    Hibbert B; MacDougall A; Labinaz M; O'Brien ER; So DY; Dick A; Glover C; Froeschl M; Marquis JF; Wells GA; Blondeau M; Le May MR
    Circ Cardiovasc Interv; 2012 Dec; 5(6):805-12. PubMed ID: 23149331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.